117 related articles for article (PubMed ID: 8826607)
1. Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix.
Kudelka AP; Verschraegen CF; Levy T; Edwards CL; Fishman A; Freedman RS; Kaplan A; Kieback DG; Mante R; Ende K; Steger M; Kavanagh JJ
Anticancer Drugs; 1996 Jun; 7(4):398-401. PubMed ID: 8826607
[TBL] [Abstract][Full Text] [Related]
2. Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.
Kudelka AP; Winn R; Edwards CL; Downey G; Greenberg H; Dakhil SR; Freedman RS; Loyer E; Rusinkiewicz J; Gacrama P; Fueger R; Kavanagh JJ
Clin Cancer Res; 1996 Aug; 2(8):1285-8. PubMed ID: 9816298
[TBL] [Abstract][Full Text] [Related]
3. An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.
Kudelka AP; Winn R; Edwards CL; Downey G; Greenberg H; Dakhil SR; Freedman RS; LoCoco S; Umbreit J; Delmore JE; Arbuck S; Loyer E; Gacrama P; Fueger R; Kavanagh JJ
Anticancer Drugs; 1997 Aug; 8(7):657-61. PubMed ID: 9311440
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Norris CM; Rossi RM; Lucarini JW; Busse PM; Poulin MD; Thornhill L; Costello R; Posner MR
J Clin Oncol; 1996 May; 14(5):1672-8. PubMed ID: 8622087
[TBL] [Abstract][Full Text] [Related]
5. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
6. Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose.
Cerrotta A; Gardan G; Cavina R; Raspagliesi F; Stefanon B; Garassino I; Musumeci R; Tana S; De Palo G
Eur J Gynaecol Oncol; 2002; 23(2):115-9. PubMed ID: 12013105
[TBL] [Abstract][Full Text] [Related]
7. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer].
Inuyama Y; Kataura A; Togawa K; Saijo S; Satake B; Takeoda S; Konno A; Ebihara S; Sasaki Y; Kida A; Kanzaki J; Ichikawa G; Kono N; Moriyama H; Kamata S; Miyake H; Sakai M; Horiuchi M; Kubota A; Tsukuda M; Matsuura H; Baba S; Saito H; Matsunaga T; Taguchi T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):107-16. PubMed ID: 9987506
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
9. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer.
Bellon JR; Lindsley KL; Ellis GK; Gralow JR; Livingston RB; Austin Seymour MM
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):393-7. PubMed ID: 10974452
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group.
Forsyth P; Cairncross G; Stewart D; Goodyear M; Wainman N; Eisenhauer E
Invest New Drugs; 1996; 14(2):203-6. PubMed ID: 8913841
[TBL] [Abstract][Full Text] [Related]
11. Taxoids in head and neck cancer: the American approach.
Forastiere AA
Acta Otorhinolaryngol Belg; 1999; 53(3):253-7. PubMed ID: 10635404
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of weekly docetaxel for patients with advanced or recurrent cancer of the cervix.
Pearl ML; Johnston CM; McMeekin DS
Gynecol Obstet Invest; 2007; 64(4):193-8. PubMed ID: 17664880
[TBL] [Abstract][Full Text] [Related]
13. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Garcia AA; Blessing JA; Vaccarello L; Roman LD;
Am J Clin Oncol; 2007 Aug; 30(4):428-31. PubMed ID: 17762444
[TBL] [Abstract][Full Text] [Related]
14. Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancer.
Shapiro JD; Millward MJ; Rischin D; Davison JD; Michael M; Francis PA; Ganju V; Toner GC
Aust N Z J Med; 1997 Feb; 27(1):40-4. PubMed ID: 9079252
[TBL] [Abstract][Full Text] [Related]
15. Feasibility study of docetaxel and nedaplatin for recurrent squamous cell carcinoma of the uterine cervix.
Watanabe Y; Nakai H; Etoh T; Kanemura K; Tsuji I; Ishizu A; Hoshiai H
Anticancer Res; 2008; 28(4C):2385-8. PubMed ID: 18751423
[TBL] [Abstract][Full Text] [Related]
16. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel in head and neck cancer: a review.
Colevas AD; Posner MR
Am J Clin Oncol; 1998 Oct; 21(5):482-6. PubMed ID: 9781605
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study.
Rose PG; Blessing JA; Ball HG; Hoffman J; Warshal D; DeGeest K; Moore DH
Gynecol Oncol; 2003 Feb; 88(2):130-5. PubMed ID: 12586591
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix.
Irvin WP; Price FV; Bailey H; Gelder M; Rosenbluth R; Durivage HJ; Potkul RK
Cancer; 1998 Jan; 82(2):328-33. PubMed ID: 9445190
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy.
Shirakawa T; Kato K; Nagashima K; Nishikawa A; Sawada R; Takahashi N; Shoji H; Sasaki Y; Honma Y; Iwasa S; Takashima A; Okita N; Hamaguchi T; Yamada Y; Shimada Y
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1207-15. PubMed ID: 25267597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
